Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

被引：0

作者：

James Yarmolinsky

Emmanouil Bouras

Andrei Constantinescu

Kimberley Burrows

Caroline J. Bull

Emma E. Vincent

Richard M. Martin

Olympia Dimopoulou

Sarah J. Lewis

Victor Moreno

Marijana Vujkovic

Kyong-Mi Chang

Benjamin F. Voight

Philip S. Tsao

Marc J. Gunter

Jochen Hampe

Andrew J. Pellatt

Paul D. P. Pharoah

Robert E. Schoen

Steven Gallinger

Mark A. Jenkins

Rish K. Pai

Dipender Gill

Kostas K. Tsilidis

机构：

[1] University of Bristol,MRC Integrative Epidemiology Unit

[2] Bristol Medical School,Population Health Sciences

[3] University of Bristol,Department of Hygiene and Epidemiology

[4] University of Ioannina Medical School,School of Translational Health Sciences

[5] University of Bristol,NIHR Bristol Biomedical Research Centre

[6] University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol,Biomarkers and Susceptibility Unit, Oncology Data Analytics Program

[7] Catalan Institute of Oncology (ICO),Colorectal Cancer Group, ONCOBELL Program

[8] L’Hospitalet de Llobregat,Department of Clinical Sciences, Faculty of Medicine

[9] Bellvitge Biomedical Research Institute (IDIBELL),Department of Medicine

[10] L’Hospitalet de Llobregat,Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine

[11] Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP),Department of Genetics

[12] University of Barcelona,Institute of Translational Medicine and Therapeutics

[13] Corporal Michael J. Crescenz VA Medical Center,Department of Medicine

[14] University of Pennsylvania Perelman School of Medicine,Stanford Cardiovascular Institute

[15] University of Pennsylvania,Nutrition and Metabolism Section, International Agency for Research on Cancer

[16] Perelman School of Medicine,Department of Medicine I

[17] University of Pennsylvania,Department of Public Health and Primary Care

[18] University of Pennsylvania,Department of Medicine and Epidemiology

[19] VA Palo Alto Epidemiology Research and Information Center for Genomics,Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital

[20] VA Palo Alto Health Care System,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health

[21] Stanford University School of Medicine,Department of Laboratory Medicine and Pathology

[22] Stanford University School of Medicine,Department of Epidemiology and Biostatistics, School of Public Health

[23] World Health Organization,undefined

[24] University Hospital Dresden,undefined

[25] Technische Universität Dresden (TU Dresden),undefined

[26] University of Texas MD Anderson Cancer Center,undefined

[27] University of Cambridge,undefined

[28] University of Pittsburgh Medical Center,undefined

[29] University of Toronto,undefined

[30] The University of Melbourne,undefined

[31] Mayo Clinic Arizona,undefined

[32] Imperial College London,undefined

[33] St Mary’s Campus,undefined

来源：

Diabetologia | 2023年 / 66卷

关键词：

ABCC8; Breast cancer; Colorectal cancer; GLP1R; Glucose-lowering drug targets; Mendelian randomisation; PPARG; Prostate cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1481 / 1500

页数：19

共 50 条

[41] The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
Hsieh, Ming-Chia
Lee, Tzu-Chi
Cheng, Shu-Min
Tu, Shih-Te
Yen, Ming-Hong
Tseng, Chin-Hsiao
EXPERIMENTAL DIABETES RESEARCH, 2012,
[42] Genetically predicted physical activity levels are associated with lower colorectal cancer risk: a Mendelian randomisation study
Zhang, Xiaomeng
Theodoratou, Evropi
Li, Xue
Farrington, Susan M.
Law, Philip J.
Broderick, Peter
Walker, Marion
Klimentidis, Yann C.
Rees, Jessica M. B.
Houlston, Richard S.
Tomlinson, Ian P. M.
Burgess, Stephen
Campbell, Harry
Dunlop, Malcolm G.
Timofeeva, Maria
BRITISH JOURNAL OF CANCER, 2021, 124 (07) : 1330 - 1338
[43] Genetically predicted physical activity levels are associated with lower colorectal cancer risk: a Mendelian randomisation study
Xiaomeng Zhang
Evropi Theodoratou
Xue Li
Susan M. Farrington
Philip J. Law
Peter Broderick
Marion Walker
Yann C. Klimentidis
Jessica M. B. Rees
Richard S. Houlston
Ian P. M. Tomlinson
Stephen Burgess
Harry Campbell
Malcolm G. Dunlop
Maria Timofeeva
British Journal of Cancer, 2021, 124 : 1330 - 1338
[44] Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms
Frans Pouwer
Diabetologia, 2015, 58 : 1378 - 1379
[45] Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes
Zanders, M. M. J.
Haak, H. R.
van Herk-Sukel, M. P. P.
Herings, R. M. C.
van de Poll-Franse, L. V.
Johnson, J. A.
DIABETES & METABOLISM, 2018, 44 (01) : 22 - 29
[46] Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms
Pouwer, Frans
DIABETOLOGIA, 2015, 58 (06) : 1378 - 1379
[47] Associations between Genetically Proxied Inhibition of Lipid-Lowering Drug Targets and Serum Micronutrients among Individuals of European Descent: A Mendelian Randomization Study
He, Jing-Yang
Zhang, Xue
Wang, Kui
Lv, Wan-Qiang
JOURNAL OF NUTRITION, 2022, 152 (05): : 1283 - 1290
[48] Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer
David Jarvis
Jonathan S Mitchell
Philip J Law
Kimmo Palin
Sari Tuupanen
Alexandra Gylfe
Ulrika A Hänninen
Tatiana Cajuso
Tomas Tanskanen
Johanna Kondelin
Eevi Kaasinen
Antti-Pekka Sarin
Jaakko Kaprio
Johan G Eriksson
Harri Rissanen
Paul Knekt
Eero Pukkala
Pekka Jousilahti
Veikko Salomaa
Samuli Ripatti
Aarno Palotie
Heikki Järvinen
Laura Renkonen-Sinisalo
Anna Lepistö
Jan Böhm
Jukka-Pekka Meklin
Nada A Al-Tassan
Claire Palles
Lynn Martin
Ella Barclay
Susan M Farrington
Maria N Timofeeva
Brian F Meyer
Salma M Wakil
Harry Campbell
Christopher G Smith
Shelley Idziaszczyk
Timothy S Maughan
Richard Kaplan
Rachel Kerr
David Kerr
Daniel D Buchanan
Aung K Win
John L Hopper
Mark A Jenkins
Noralane M Lindor
Polly A Newcomb
Steve Gallinger
David Conti
Fred Schumacher
British Journal of Cancer, 2016, 115 : 266 - 272
[49] Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer
Jarvis, David
Mitchell, Jonathan S.
Law, Philip J.
Palin, Kimmo
Tuupanen, Sari
Gylfe, Alexandra
Hanninen, Ulrika A.
Cajuso, Tatiana
Tanskanen, Tomas
Kondelin, Johanna
Kaasinen, Eevi
Sarin, Antti-Pekka
Kaprio, Jaakko
Eriksson, Johan G.
Rissanen, Harri
Knekt, Paul
Pukkala, Eero
Jousilahti, Pekka
Salomaa, Veikko
Ripatti, Samuli
Palotie, Aarno
Jarvinen, Heikki
Renkonen-Sinisalo, Laura
Lepisto, Anna
Bohm, Jan
Mecklin, Jukka-Pekka
Al-Tassan, Nada A.
Palles, Claire
Martin, Lynn
Barclay, Ella
Farrington, Susan M.
Timofeeva, Maria N.
Meyer, Brian F.
Wakil, Salma M.
Campbell, Harry
Smith, Christopher G.
Idziaszczyk, Shelley
Maughan, Timothy S.
Kaplan, Richard
Kerr, Rachel
Kerr, David
Buchanan, Daniel D.
Win, Aung K.
Hopper, John L.
Jenkins, Mark A.
Lindor, Noralane M.
Newcomb, Polly A.
Gallinger, Steve
Conti, David
Schumacher, Fred
BRITISH JOURNAL OF CANCER, 2016, 115 (02) : 266 - 272
[50] blood pressure-lowering and risk of cancer: an individual participant-level data meta-analysis and mendelian randomisation studies
Nazarzadeh, M.
Copland, E.
Byrne, K. Smith
Canoy, D.
Bidel, Z.
Woodward, M.
Chalmers, J.
Teo, K.
Pepine, C. J.
Davis, B. R.
Kjeldsen, S.
Sundstrom, J.
Rahimi, K.
EUROPEAN HEART JOURNAL, 2024, 45

← 1 2 3 4 5 →